These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1627787)

  • 21. Functional distinctions between MRL-lpr and MRL-gld lymphocytes. Normal cells reverse the gld but not lpr immunoregulatory defect.
    Ettinger R; Wang JK; Bossu P; Papas K; Sidman CL; Abbas AK; Marshak-Rothstein A
    J Immunol; 1994 Feb; 152(4):1557-68. PubMed ID: 8120369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice.
    Takahashi S; Fossati L; Iwamoto M; Merino R; Motta R; Kobayakawa T; Izui S
    J Clin Invest; 1996 Apr; 97(7):1597-604. PubMed ID: 8601623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aberrant regulation of IL-1 expression in macrophages from young autoimmune-prone mice.
    Donnelly RP; Levine J; Hartwell DQ; Frendl G; Fenton MJ; Beller DI
    J Immunol; 1990 Nov; 145(10):3231-9. PubMed ID: 2230116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ly-1 B helper cells in autoimmune "viable motheaten" mice.
    Sherr DH; Dorf ME; Gibson M; Sidman CL
    J Immunol; 1987 Sep; 139(6):1811-7. PubMed ID: 2957439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CBA/N X-linked defect delays expression of the Y-linked accelerated autoimmune disease in BXSB mice.
    Golding B; Golding H; Foiles PG; Morton JI
    J Immunol; 1983 Mar; 130(3):1043-6. PubMed ID: 6600468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intrinsic defects in macrophage IL-12 production associated with immune dysfunction in the MRL/++ and New Zealand Black/White F1 lupus-prone mice and the Leishmania major-susceptible BALB/c strain.
    Alleva DG; Kaser SB; Beller DI
    J Immunol; 1998 Dec; 161(12):6878-84. PubMed ID: 9862720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Production and roles of IL-6, IL-10, and IL-13 in B-lymphocyte malignancies and in B-lymphocyte hyperactivity of HIV infection and autoimmunity.
    Emilie D; Zou W; Fior R; Llorente L; Durandy A; Crevon MC; Maillot MC; Durand-Gasselin I; Raphael M; Peuchmaur M; Galamaud P
    Methods; 1997 Jan; 11(1):133-42. PubMed ID: 8990099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of granulomatous arteritis in MRL/Mp autoimmune disease mice bearing lymphoproliferative genes. The use of mouse genetics to dissociate the development of arteritis and glomerulonephritis.
    Nose M; Nishimura M; Kyogoku M
    Am J Pathol; 1989 Aug; 135(2):271-80. PubMed ID: 2782373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymorphisms in the Il12b gene affect structure and expression of IL-12 in NOD and other autoimmune-prone mouse strains.
    Ymer SI; Huang D; Penna G; Gregori S; Branson K; Adorini L; Morahan G
    Genes Immun; 2002 May; 3(3):151-7. PubMed ID: 12070779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A serum-derived molecule from autoimmune viable motheaten mice potentiates the action of a B cell maturation factor.
    Sidman CL; Shultz LD; Evans R
    J Immunol; 1985 Aug; 135(2):870-2. PubMed ID: 3891855
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of immunodeficiency on diabetogenesis in genetically diabetic (db/db) mice.
    Leiter EH; Prochazka M; Shultz LD
    J Immunol; 1987 May; 138(10):3224-9. PubMed ID: 3553324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential gene expression in autoimmune mice.
    Mountz JD; Mushinski JF; Steinberg AD
    Surv Immunol Res; 1985; 4(1):48-64. PubMed ID: 3890056
    [No Abstract]   [Full Text] [Related]  

  • 33. Sustained interleukin-6 signalling leads to the development of lymphoid organ-like structures in the lung.
    Goya S; Matsuoka H; Mori M; Morishita H; Kida H; Kobashi Y; Kato T; Taguchi Y; Osaki T; Tachibana I; Nishimoto N; Yoshizaki K; Kawase I; Hayashi S
    J Pathol; 2003 May; 200(1):82-7. PubMed ID: 12692845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biological and clinical aspects of interleukin 6.
    Hirano T; Akira S; Taga T; Kishimoto T
    Immunol Today; 1990 Dec; 11(12):443-9. PubMed ID: 2127356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anticytokine therapy in autoimmune diseases.
    Nishimoto N; Kishimoto T; Yoshizaki K
    Intern Med; 1999 Feb; 38(2):178-82. PubMed ID: 10225680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of the lpr mutation on elimination and inactivation of self-reactive B cells.
    Rathmell JC; Goodnow CC
    J Immunol; 1994 Sep; 153(6):2831-42. PubMed ID: 8077685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective reduction of V alpha 14+ NK T cells associated with disease development in autoimmune-prone mice.
    Mieza MA; Itoh T; Cui JQ; Makino Y; Kawano T; Tsuchida K; Koike T; Shirai T; Yagita H; Matsuzawa A; Koseki H; Taniguchi M
    J Immunol; 1996 May; 156(10):4035-40. PubMed ID: 8621946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice.
    Brandt SJ; Bodine DM; Dunbar CE; Nienhuis AW
    J Clin Invest; 1990 Aug; 86(2):592-9. PubMed ID: 2384605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin-6 overexpression cannot generate serious disorders in severe combined immunodeficiency mice.
    Katsume A; Miyai T; Suzuki H; Moriguchi Y; Kawata H; Tatsumi T; Suematsu S; Kishimoto T; Ohsugi Y
    Clin Immunol Immunopathol; 1997 Feb; 82(2):117-24. PubMed ID: 9000479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular genetics of murine lupus models.
    Theofilopoulos AN; Kofler R; Singer PA; Dixon FJ
    Adv Immunol; 1989; 46():61-109. PubMed ID: 2675565
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.